Filing metadata

Accession number
0001859061-23-000002
Form type
Form 4
Filer
A2A Pharmaceuticals, Inc.
CIK
CIK 1859061
Filed
Apr 06, 2023
Reporting period
Mar 31, 2023
Description
Insider transaction

Explore SEC Filings Hub